Validation of the Itch Severity Item as a Measurement Tool for Pruritus in Patients with Psoriasis: Results from a Phase 3 Tofacitinib Program

Validation of the Itch Severity Item as a Measurement Tool for Pruritus in Patients with Psoriasis: Results from a Phase 3 Tofacitinib Program

Tofacitinib is an oral Janus kinase inhibitor. This post-hoc analysis aimed to investigate the psychometric properties of the Itch Severity Item (ISI), a numeric rating scale from 0 (no itching) to 10 (worst possible itching) for pruritus in psoriasis, and review the effect of tofacitinib on pruritu...

Full description

Saved in:
Bibliographic Details
Main Authors: Sonja Ständer (Author), Thomas Luger (Author), Joseph C. Cappelleri (Author), Andrew G. Bushmakin (Author), Carla Mamolo (Author), Michael A. Zielinski (Author), Anna M Tallman (Author), Gil Yosipovitch (Author)
Format: Book
Published: Medical Journals Sweden, 2017-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items